MedX Announces Application for Final Extension of Non-Brokered Private Placement

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated March 16, 2026, when it announced application for an extension of time within which to effect further closings of the Non-brokered Private Placement to accredited investors of Series IV Convertible Loan Notes (“Series IV Notes”) originally announced in its Press Release dated February 2, 2026, and the First Closing which was announced in.